Natural Alternatives International Inc $NAII
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
Snapshot
- Exchange
- Nasdaq Global Market
- Sector
- Medicinal Chemicals & Botanical Products
- Headquarters
- Carlsbad, CA
- Fiscal year end
- June 30
- Shares outstanding
- 22,113,000 [10-K 2026-09-28]
What the company doesAI summary of filing
Natural Alternatives International manufactures nutritional supplements on a private-label contract basis for companies that market vitamins, minerals, herbs, and other nutritional products to consumers in the U.S. and internationally. The company also commercializes its patent estate related to beta-alanine raw material through direct sales and licensing under the CarnoSyn®, SR CarnoSyn®, CarnoSyn® 4X, and TriBsyn® trademarks. In fiscal 2026, the company generated $142.5 million in revenue, with 94 percent from private-label contract manufacturing and 6 percent from patent and trademark licensing. The company operates manufacturing facilities in California and Switzerland and is a revenue-generating business. [10-K 2026-09-28]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| 105 months to Sep 2031 | $32.70M | −$2.38M | — | — | [10-Q 2023-05-15] |
| FY ended Jun 2026 | $142.51M | −$20.70M | −$8.92M | $7.39M | [10-K 2026-09-28] |
| FY ended Jun 2025 | $129.86M | −$13.57M | $5.93M | $12.32M | [10-K 2026-09-28] |
Capital structure and dilution
| Date | Shares outstanding | Filing |
|---|---|---|
| 2024-11-13 | 6,198,778 | [10-Q 2024-11-13] |
| 2025-02-14 | 6,198,778 | [10-Q 2025-02-14] |
| 2025-05-14 | 6,178,898 | [10-Q 2025-05-14] |
| 2025-09-23 | 6,176,778 | [10-K 2025-09-23] |
| 2025-11-12 | 6,176,778 | [10-Q 2025-11-12] |
| 2026-02-13 | 6,176,778 | [10-Q 2026-02-13] |
| 2026-05-18 | 6,275,229 | [10-Q 2026-05-19] |
| 2026-09-28 | 22,113,000 | [10-K 2026-09-28] |
Listing status
Current status: No Form 8-K Item 3.01 (listing notice) filings in the last 24 months, as of 2026-10-11.
Who owns it
| Date | Insider | Type | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-03-06 | Wolf Kenneth | other | 5,151 | $2.73 | [4 2026-03-10] |
| 2026-03-06 | Wolf Kenneth | grant | 15,000 | — | [4 2026-03-10] |
| 2026-03-06 | Fortin Michael E | other | 4,308 | $2.73 | [4 2026-03-10] |
| 2026-03-06 | Fortin Michael E | grant | 12,000 | — | [4 2026-03-10] |
| 2026-03-06 | Ledoux Mark A | other | 3,484 | $2.73 | [4 2026-03-10] |
| 2026-03-06 | Ledoux Mark A | grant | 20,000 | — | [4 2026-03-10] |
| 2026-03-06 | Dunn Alan G | grant | 8,000 | — | [4 2026-03-10] |
| 2026-03-06 | Matherly Laura Kay | grant | 8,000 | — | [4 2026-03-10] |
| 2026-03-06 | Ramanathan Guru | grant | 8,000 | — | [4 2026-03-10] |
| 2026-03-06 | Ledoux Mark A | buy | 532 | $2.80 | [4 2026-03-06] |
| 2026-03-05 | Ledoux Mark A | buy | 218 | $2.75 | [4 2026-03-06] |
| 2026-03-04 | Ledoux Mark A | buy | 500 | $2.77 | [4 2026-03-06] |
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-09-28 | 10-K | Annual report |
| 2026-05-19 | 10-Q | Quarterly report |
| 2026-05-18 | NT 10-Q | Notice of late quarterly report |
| 2026-05-01 | 8-K | Director or officer change |
| 2026-03-20 | 8-K | Director or officer change |
| 2026-02-13 | 10-Q | Quarterly report |
| 2026-01-21 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2025-12-17 | 8-K | Material agreement entered |
| 2025-12-12 | 8-K | Shareholder vote results |
| 2025-11-12 | 10-Q | Quarterly report |
| 2025-10-23 | DEF 14A | Proxy statement |
Alerts for $NAII
Email me when Natural Alternatives International Inc files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.